Baxter's most recent trend suggests a bearish bias. One trading opportunity on Baxter is a Bear Call Spread using a strike $74.50 short call and a strike $80.00 long call offers a potential 6.8% return on risk over the next 9 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $74.50 by expiration. The full premium credit of $0.35 would be kept by the premium seller. The risk of $5.15 would be incurred if the stock rose above the $80.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Baxter is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Baxter is bearish.
The RSI indicator is at 23.51 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Baxter
Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite
Thu, 07 Aug 2014 15:18:59 GMT
noodls – Singapore-Based Facility Enhances Baxter's Global Capabilities to Support the Treatment Needs of Hemophilia Patients Worldwide SINGAPORE–(BUSINESS WIRE)–Aug. 7, 2014– Baxter International Inc. (NYSE: …
Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite
Thu, 07 Aug 2014 13:00:00 GMT
Business Wire – SINGAPORE–(BUSINESSWIRE)– Baxter International Inc. (NYSE: BAX) today announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant …
Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite
Thu, 07 Aug 2014 13:00:00 GMT
Business Wire – Baxter International Inc. today announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant
BAXTER INTERNATIONAL INC Financials
Wed, 06 Aug 2014 17:04:12 GMT
Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives
Tue, 05 Aug 2014 13:16:39 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook